About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
-Advanced
-Search Guidelines
Home
Advanced Search
Go to Top
Go to Top
Go to Bottom
Go to Bottom
7 results
1 of 1
1
Influence of CYP2D6 Polymorphism on the Pharmacokinetic/Pharmacodynamic Characteristics of Carvedilol in Healthy Korean Volunteers
Eben Jung, Sunae Ryu, Zewon Park, Jong-Gu Lee, Jung-Yeon Yi, Doo Won Seo, Juhyun Lee, Ho-Sang Jeong, Jeong Mi Kim, Woo-Yong Oh
J Korean Med Sci.
2018;33(27):e182. Published online 2018 May 23 DOI:
http://dx.doi.org/10.3346/jkms.2018.33.e182
2
Prediction and visualization of CYP2D6 genotype-based phenotype using clustering algorithms
Eun-Young Kim, Sang-Goo Shin, Jae-Gook Shin
Transl Clin Pharmacol.
2017;25(3):147-152. Published online 2017 September 15 DOI:
http://dx.doi.org/10.12793/tcp.2017.25.3.147
3
Genetic Polymorphism of CYP2D6 and Clomiphene Concentrations in Infertile Patients with Ovulatory Dysfunction Treated with Clomiphene Citrate
Misuk Ji, Kwang-Rae Kim, Woochang Lee, Wonho Choe, Sail Chun, Won-Ki Min
J Korean Med Sci.
2016;31(2):310-314. Published online 2016 January 26 DOI:
http://dx.doi.org/10.3346/jkms.2016.31.2.310
4
Nonresponders to Daily Paroxetine and Another SSRI in Men With Lifelong Premature Ejaculation: A Pharmacokinetic Dose-Escalation Study for a Rare Phenomenon
Paddy KC Janssen, Daan Touw, Dave H. Schweitzer, Marcel D. Waldinger
Korean J Urol.
2014;55(9):599-607. Published online 2014 September 5 DOI:
http://dx.doi.org/10.4111/kju.2014.55.9.599
5
Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment
Hyung Seok Park, Ji-Yeob Choi, Mi-Jeong Lee, Seho Park, Chang-Woo Yeo, Sang Seop Lee, Jae-Gook Shin, Byeong-Woo Park
J Korean Med Sci.
2011;26(8):1007-1013. Published online 2011 July 27 DOI:
http://dx.doi.org/10.3346/jkms.2011.26.8.1007
6
CYP1A2 activity as a risk factor for bladder cancer
Seong Won Lee, In Jin Jang, Sang Goo Shin, Kyeong Hoon Lee, Dong Seok Yim, Si Whang Kim, Seong Joon Oh, Sun Hee Lee
J Korean Med Sci.
1994;9(6):482-489. Published online 2009 June 19 DOI:
http://dx.doi.org/10.3346/jkms.1994.9.6.482
7
A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication
Soo-Youn Lee, Chang-Seok Ki, Kyung Sue Hong, Jong Won Kim
J Korean Med Sci.
2004;19(5):750-752. Published online 2004 October 30 DOI:
http://dx.doi.org/10.3346/jkms.2004.19.5.750
1 of 1